key: cord-0823416-jbob9jyq authors: Aizer, Adva; Noach-Hirsh, Meirav; Dratviman-Storobinsky, Olga; Nahum, Ravit; Machtinger, Ronit; Yung, Yuval; Haas, Jigal; Orvieto, Raoul title: The effect of COVID-19 immunity on frozen-thawed embryo transfer cycles outcome. date: 2022-01-10 journal: Fertil Steril DOI: 10.1016/j.fertnstert.2022.01.009 sha: c0c29d23fd997a02f629503c04a39e74d77bbebe doc_id: 823416 cord_uid: jbob9jyq Objective To study the effect of patients' immunization following COVID-19 infection or mRNA SARS-CoV-2 vaccine on frozen-thawed embryo transfer (FET). Design A cohort retrospective study Setting Tertiary University Affiliated Medical Center Patients All consecutive patients undergoing FET cycles in our center. The study group (immune- group) consisted of patients treated during the COVID-19 pandemic (between January 2021 to August 2021), who either recovered from COVID-19 infection or received the mRNA SARS-CoV-2 vaccine. The control groups consisted of patients treated during the COVID-19 pandemic (between January 2021 to August 2021) but were not infected nor received the mRNA SARS-CoV-2 vaccine (not-immune2021 group) and those patients treated between January 2019 to August 2019 (prior to the pandemic) (not-immune2019 group). Intervention FET cycles Main outcome measures Ongoing pregnancy rates and FET cycles' characteristics. Data on patient age and variables related to infertility treatment were collected from the patient records. Results During the study periods, 428 patients underwent 672 FET cycles. The immune group consisted of 141 patients who underwent 264 FET cycles (44 in post-infection and 220 in post-vaccination), while the non-immune2021 and 2019 groups consisted of 93 and 194 patients, undergoing 125 and 283 FET cycles respectively. Patients' characteristics and the types of endometrial preparations were comparable between the study groups. Implantation rate, clinical and ongoing pregnancy rates per transfer were similar between the study groups (immune- group: post-infection and post-vaccination; not-immune2021 group; not-immune2019 group). Conclusions COVID-19 infection or vaccination did not affect patients' performance or implantation in their subsequent FET cycle. The coronavirus disease , first reported in Wuhan, China in December 2019, rapidly spread globally. In March 2020, it was declared by the World Health Organization (WHO) as a public health emergency pandemic of international concern (1-3). Coronavirus disease is caused by a single, positive-strand RNA virus SARS-CoV-2 comprises a spike protein (S), a membrane protein, an envelope protein, nucleocapsids, hemagglutinin-esterase dimers, and its genetic material (4) . The S protein is responsible for SARS-CoV-2's high affinity for human angiotensinconverting enzyme 2 (ACE2) receptor allowing the viral entry into cells (5) . Some studies focused on gene expression of the ACE2 receptor in the endometrium in order to determine the risk of endometrial infection resulting in low expression of ACE2 in the uterus surrounding (6) (7) . Israel was one of the first countries that widely vaccinated its population using The type of endometrial preparation used was decided by the treating physician and largely depended on the fashion at the time. Endometrial preparation and transfer procedure were performed as previously described (10) . Patients ages 18-38 years were included. None of the embryos underwent PGT-A, which is not a common practice in our country. Embryos were cryopreserved by vitrification, using a vitrification kit (SAGE Vitrification Kit, SAGE Media, USA), on cleavage or blastocyst stages. The vitrification-warming method was performed as previously describes (11) . Only highquality embryos (HQE) were considered for vitrification. The number of embryos transferred complied with the Israeli national minister of health guidelines and was confirmed by patient approval or request. According to our laboratory procedure, HQE eligible for vitrification had the following morphological criteria: Cleaved embryos-6-8 cells on day 3, with up to 10% fragmentation, absence of vacuoles, and up to minimal asymmetric blastomeres; grading of blastocyst was according with Gardner method (12-13), based on the assessment of the inner cell mass and trophectoderm appearance. Only type A and B blastocysts were vitrified. Data on patient age and variables related to infertility treatment were collected from the patient records. Clinical outcomes were assessed and compared between the study groups (immune-group; not-immune2021 group; not-immune2019 group). Clinical pregnancy was defined as visualization of a gestational sac and fetal cardiac J o u r n a l P r e -p r o o f activity on transvaginal ultrasound. Embryo implantation rate was defined as the number of gestational sacs observed, divided by the number of embryos transferred. The primary outcome measure was the clinical pregnancy rate. Secondary outcome measures were FET cycle characteristics and implantation rate. In order to investigate the effect of SARS-CoV-2 vaccination/infection on FET cycles outcome, a sample size of 290 participants was estimated to be sufficient to reveal a difference ongoing pregnancy rate from a baseline of 20% to a proposed 30% after vaccination/infection with a type 1 error (alpha) of 5% and a power of 80%. Continuous variables were tested for normal distribution before using parametric statistics. For multiple comparisons, One-way ANOVA with post hoc Bonferroni and Kruskal-Wallis tests were used whenever appropriate. Categorical variables were analyzed with chi-square test. Significance was accepted at P < 0.05. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 -11 A Novel Coronavirus from Patients with Pneumonia in China Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle? SARS-CoV-2 infection risk assessment in the endometrium: viral infectionrelated gene expression across the menstrual cycle Does COVID-19 infection influence patients' performance during IVF-ET cycle?: an observational study Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? Natural cycle frozen-thawed embryo transfer-can we improve cycle outcome? Does the number of embryos loaded on a single cryo-carrier affect post-vitrification survival rate? Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer Physiology and culture of the human blastocyst Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of Does immunotherapy for treatment of reproductive failure enhance live births? Pregnancy and autoimmunity What do we really know about autoantibody abnormalities and reproductive failure: a critical review The Vasoactive Peptide Angiotensin-(1-7), Its Receptor Mas and the Angiotensin-converting Enzyme Type 2 are Expressed in the Human Endometrium We have no one to acknowledge.